REGENERX BIOPHARMACEUTICALS INC (14)
Browse by Contract Category
Contracts
-
Registration Rights Agreement between the Company and various investors dated June 28, 2021
(Filed With SEC on August 6, 2021)
-
Lock-Up Agreement between Company and various investors dated June 30, 2021
(Filed With SEC on August 6, 2021)
-
Amendment N. 1 to License Agreement dated February 25, 2019 between the Company and Lees Pharmaceutical (HK) Limited
(Filed With SEC on November 14, 2019)
-
2018 Equity Incentive Plan
(Filed With SEC on March 29, 2019)
-
Securities Purchase Agreement between the Company and various investors dated June 28, 2021
(Filed With SEC on August 6, 2021)
-
Form of Series A Common Stock Purchase Warrant dated June 30, 2021
(Filed With SEC on August 6, 2021)
-
Form of Series B Common Stock Purchase Warrant dated June 30, 2021
(Filed With SEC on August 6, 2021)
-
Form of Convertible Note Purchase Agreement October 2020
(Filed With SEC on November 13, 2020)
-
Form of Convertible Promissory Note October 2020
(Filed With SEC on November 13, 2020)
-
Form of Common Stock Warrant October 2020
(Filed With SEC on November 13, 2020)
-
Amendment No. 1 to RGN-259 License Agreement (PAN ASIA) dated September 17, 2019 between Company and GtreeBNT Co., Ltd
(Filed With SEC on November 14, 2019)
-
Form of Convertible Note Purchase Agreement February 2019
(Filed With SEC on May 15, 2019)
-
Form of Convertible Promissory Note February 2019
(Filed With SEC on May 15, 2019)
-
Form of Common Stock Warrant February 2019
(Filed With SEC on May 15, 2019)